How to use this tool

Demo mode

A short orientation so you can run a credible AKI audit on your ward, division or trust.

Step 1
Review the standard

Familiarise yourself with NICE NG148 and any local AKI policy or care bundle.

  • Confirm the KDIGO/NICE AKI trigger definitions you will use
  • Note locally agreed timeframes for recognition and repeat creatinine
Step 2
Set up the project

Open Project setup and complete the metadata so submissions are correctly attributed.

  • Project name, site, lead clinician, dates
  • Inclusion and exclusion criteria
  • Local targets (defaults follow NICE NG148)
Step 3
Identify eligible cases

Use your laboratory AKI alert feed, e-Obs system or ward review to find consecutive AKI triggers.

  • Prefer consecutive sampling to reduce selection bias
  • Apply inclusion / exclusion criteria before data entry
Step 4
Complete the data collection form

Enter one form per AKI trigger event. The form takes 3–5 minutes per case.

  • Use a pseudonymised case ID — no patient identifiers
  • Use clinical notes to confirm recognition time and repeat creatinine timing
Step 5
Review the dashboard

Check compliance against your targets, identify themes and missing data.

  • Filter by site, ward and AKI stage
  • Identify improvement priorities
Step 6
Generate outputs and act

Export evidence, share with governance and design the improvement intervention.

  • Use the export centre for CSV, PDF and PowerPoint outputs
  • Plan PDSA cycles based on the gaps identified
Information governance

Use a pseudonymised case identifier (e.g. study number). Do not enter NHS numbers, names, dates of birth or other directly identifiable data.

Confirm local Caldicott / IG approval before running the audit outside demo mode.

Time required

Setup: ~5 minutes

Per case: ~3–5 minutes

Recommended sample: 20–50 consecutive AKI triggers

Outputs you'll get

• Live dashboard with compliance KPIs

• CSV / Excel data export

• PDF QI project report

• Conference poster draft

• ARCP evidence summary

Generation enabled in Phase 3.